Evidence map›Paper›PMID 24622471›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance.

Erin N Bobeck, QiLiang Chen, Michael M Morgan, Susan L Ingram

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. GABAergic neurons in the ventrolateral periaqueductal gray mediate fentanyl withdrawal and self-administration in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Divergent modulation of pain and anxiety by GABAergic neurons in the ventrolateral periaqueductal gray and dorsal raphe.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Erin N BobeckDepartment of Psychology, Washington State University, Vancouver, WA, USA.
QiLiang ChenDepartment of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Michael M MorganDepartment of Psychology, Washington State University, Vancouver, WA, USA.
Susan L IngramDepartment of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.
Oregon Health & Science University · USWashington State University Vancouver · US

Funding

Psychostimulants induce long-term changes in nociception.R01DA027625 · NIDA · WASHINGTON STATE UNIVERSITY · PI AICHER, SUE A, INGRAM, SUSAN L · 2009 to 2013
$2.3M
Cellular Mechanisms of Opioid ToleranceR01DA015498 · NIDA · WASHINGTON STATE UNIVERSITY · PI MORGAN, MICHAEL M · 2003 to 2010
$2.0M
NIDA NIH HHS DA015498NIDA NIH HHS DA027625NIDA NIH HHS R01 DA015498NIDA NIH HHS R01 DA027625
6 · The paper itself

Abstract

Opioid inhibition of presynaptic GABA release in the ventrolateral periaqueductal gray (vlPAG) activates the descending antinociception pathway. Tolerance to repeated opioid administration is associated with upregulation of adenylyl cyclase activity. The objective of these studies was to test the hypothesis that adenylyl cyclase contributes to opioid tolerance by modulating GABA neurotransmission. Repeated microinjections of morphine or the adenylyl cyclase activator NKH477 into the vlPAG decreased morphine antinociception as would be expected with the development of tolerance. Conversely, microinjection of the adenylyl cyclase inhibitor SQ22536 reversed both the development and expression of morphine tolerance. These behavioral results indicate that morphine tolerance is dependent on adenylyl cyclase activation. Electrophysiological experiments revealed that acute activation of adenylyl cyclase with forskolin increased the frequency of presynaptic GABA release. However, recordings from rats treated with repeated morphine administration did not exhibit increased basal miniature inhibitory postsynaptic current (mIPSC) frequency but showed a decrease in mean amplitude of mIPSCs indicating that repeated morphine administration modulates postsynaptic GABAA receptors without affecting the probability of presynaptic GABA release. SQ22536 reversed this change in mIPSC amplitude and inhibited mIPSC frequency selectively in morphine tolerant rats. Repeated morphine or NKH477 administration also decreased antinociception induced by microinjection of the GABAA receptor antagonist bicuculline, further demonstrating changes in GABA neurotransmission with morphine tolerance. These results show that the upregulation of adenylyl cyclase caused by repeated vlPAG morphine administration produces antinociceptive tolerance by modulating both pre- and postsynaptic GABA neurotransmission.

Indexed as

AdenineAdenylyl Cyclase InhibitorsAdenylyl CyclasesAnalgesics, OpioidAnimalsBicucullineColforsinDrug ToleranceEnzyme ActivatorsEnzyme InhibitorsGABA-A Receptor Antagonistsgamma-Aminobutyric AcidInhibitory Postsynaptic PotentialsMaleMiniature Postsynaptic PotentialsMorphine9-(tetrahydro-2-furyl)-adenineAdenineAdenylyl Cyclase InhibitorsAdenylyl CyclasesAnalgesics, OpioidBicucullineColforsinEnzyme ActivatorsEnzyme InhibitorsGABA-A Receptor Antagonistsgamma-Aminobutyric AcidMorphineReceptors, GABA-A

Identifiers

PMID24622471
PMCPMC4104331
OpenAlexW1999474262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.